Press Release
Eclevar MedTech today announced the appointment of Nancy Boodhun as Chief Clinical Operations & Strategy Officer. With 25+ years of experience across clinical research, regulatory strategy, and global clinical operations, Nancy joins Eclevar to strengthen the company's ability to design and deliver robust clinical evidence programs aligned with regulator expectations and manufacturers' business objectives, whilst ensuring client needs are met through the operational delivery.
"Eclevar's mission is to simplify regulatory complexity and accelerate innovation without compromising the quality of clinical evidence," said Chems Hachani, CEO & Founder of Eclevar MedTech. "Nancy's arrival is a major step forward. Her deep expertise in orthopaedics, clinical investigations, and global evidence strategy will further elevate how we execute and advise across complex programs."
Nancy's career spans the full spectrum of medical device clinical research from strategic planning to operational delivery. Her experience from a CRO and a manufacturer's perspective, provides her with unique insight to ensure success in clinical projects. During her 12 year tenure at Johnson & Johnson, she led global clinical strategies for orthopaedic implants, managing complex Class III device studies from protocol development through key regulatory milestones, and provided oversight of Investigator Initiated study portfolios.
Nancy's appointment strengthens Eclevar's ability to deliver world-class clinical operations and strategic evidence planning, particularly for:
Nancy brings an evidence-first approach: beyond trial execution, she understands that successful clinical evidence strategies that are built from the start to meet evaluator expectations, withstand scrutiny, and de-risk regulatory timelines.
"The best clinical evidence is evidence that's designed right from the start," said Nancy. "I'm excited to join Eclevar MedTech, where partnering with and supporting our clients in achieving their clinical evidence goals is central to everything we do. We work alongside manufacturers to build integrated clinical strategies that align operations, regulatory requirements, and development objectives, enabling them to accelerate their path to market with confidence with a partner who truly understands their challenges."
With Nancy leading clinical operations and strategy, Eclevar strengthens its promise: clinical evidence that is not only collected, but strategically designed, operationally executed, and regulatory-ready from day one.
Eclevar MedTech is a CRO specializing in medical devices. Eclevar supports manufacturers in designing and executing clinical investigations and post-market programs, with a strong focus on compliance, operational efficiency, and evidence quality.
To discuss a clinical investigation, evidence strategy, or PMCF program:
Nancy is available for interviews on: clinical evidence strategy, global clinical operations, medical device clinical investigations, PMCF, and regulatory expectations.
